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Abstract 
Aptamers are chemically produced oligonucleotides, able to bind a variety of targets such as drugs, proteins and 
pathogens with high sensitivity and selectivity. Therefore, aptamers are largely employed for  producing label-free 
biosensors, with  significant applications in diagnostics and drug delivery.  In particular, the anti-thrombin 
aptamers are biomolecules of high interest for clinical use, because of their ability to recognize and bind the 
thrombin enzyme. Among them, the DNA 15-mer thrombin-binding aptamer (TBA), has been widely explored 
concerning both its structure, which was resolved with different techniques, and its function, especially about the 
possibility of using it as the active part of  biosensors. This paper proposes a microscopic model of the electrical 
properties of TBA and the aptamer-thrombin complex, combining information from both structure and function. 
The novelty consists in   describing both the aptamer alone and the complex as an impedance network, thus going 
deeper inside the issues addressed in an emerging electronics branch known as proteotronics. The theoretical 
results are compared and validated with Electrochemical Impedance Spectroscopy  measurements  reported in the 
literature. Finally, the model suggests resistance measurements as a novel tool for testing aptamer-target affinity. 
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I. Introduction 
Aptamers are target-specific single-stranded DNA, RNA or peptide sequences mainly 
generated on demand by an in vitro selection and amplification method called Systematic 
Evolution of Ligands by EXponential Enrichment (SELEX), which involves repetitive cycles 
of binding, recovery and amplification steps (Yüce et al., 2015). These techniques ensure the 
production of oligonucleotides specific for targeted disease therapies (Zhou and Rossi, 2014) 
and medical diagnosis (Jo and Ban, 2016). Recently, computational approaches have been 
proposed for in silico selection of aptamers  with a higher target-binding ability, to be used for 
clinical diagnosis and medicine (Bini et al., 2011). Aptamers can be used under a broad range 
of experimental conditions as a result of their thermal and chemical stability, furthermore, they 
can be readily synthesized in large quantities at relatively low cost (Yüce et al., 2015). This 
constitutes a great advantage compared to antibody (Schlecht et al., 2006) production which is 
laborious and requires animal sacrifice.  Therefore, academic and commercial interest in the 
field is growing, thus promising a substantial progress over the coming years (Yüce et al., 
2015). 
 
Particular attention is devoted to the DNA 15-mer aptamer which binds the exosite II of 
thrombin, TBA, whose efficacy in inhibiting platelet thrombus formation has been known for a 
long time  (Li, et al. 1994). Traditional therapies against blood coagulation are based on the use 
of heparin and direct inhibitors like hirudin and bivalirudin (Dahlbäck, 2005). The side effects 
of these drugs are well known, the most relevant is bleeding (Ni et al., 2011, Barbone et al., 
2012).  TBA is under clinical trial and its activity and side effects  can be controlled by 
matched antidotes (Rusconi et al., 2004).  
Really the therapeutic aptamers tested to date have shown good safety margins between 
the pharmacologically effective dose and the toxicologically established no-adverse-effect 
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levels (Bouchard et al., 2010). Moreover, due to the facility of production and amplification,  
TBA, as well as many other aptamers, has been recently used in the design of several 
biosensors, also known as aptasensors ( Iliuk et al., 2011;  Jo and Ban, 2016; Shen et al., 2016; 
Wang et al., 2016). Aptasensors are interesting tools offering convenient methodologies for 
detecting and measuring the levels of specific proteins in biological and environmental samples 
whose detection, identification and quantification can be very complex, expensive and time 
consuming (Yüce et al., 2015).  
Among aptasensors, a significant role is played by label-free biosensors, designed with 
high detection sensitivity and selectivity (Strehlitz et al., 2008). In particular, electrochemical 
transduction of biosensors using aptamers as bioreceptors include methods like 
Electrochemical Impedance Spectroscopy (EIS), differential pulse voltammetry, alternating 
current voltammetry, square wave voltammetry, potentiometry or amperometry (Rodriguez et 
al.,2005; Strehlitz et al., 2008). 
.  
Xu et al. (2005) proposed an EIS method for aptamer modified array electrodes as a promising 
label-free detection for immunoglobulins E (IgE). They found lower background noise, 
decreased non specific adsorption, and larger differences in the impedance signals due to the 
small size and simple structure of the aptamers in comparison to the antibody (Xu et al., 2005). 
Cai et al. (2006) proposed an aptamer-based biosensing assay for label-free protein detection 
and quantification by measuring the change in electrochemical impedance upon protein–
aptamer complex formation, monitoring the interfacial electron transfer resistance with 
electrochemical impedance spectroscopy (EIS). TBA showed high binding affinity and 
specificity to its target protein and the impedance detection assay was able to achieve a reliable 
and sensitive quantification of thrombin (Cai et al., 2006). 
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Although much work has been made in last 20 years a deep understanding of the mechanisms 
of TBA-thrombin recognition and capture is far to be reached.  
 
This paper proposes a microscopic model of the electrical properties of the aptamer-thrombin 
complex, combining  information from both structure and function of the biomolecule. 
Hereafter we use the term biomolecule for indicating both the aptamer and the aptamer-protein 
complex.   
In particular we analyze  the results of the experiment performed by Cai et al. (2006) that 
investigated the in vitro response of TBA samples to different thrombin concentrations.  
Those experimental data are here described within the framework of proteotronics, i.e. a 
structure-function representation of the aptamer, able to connect its electrical response at 
thrombin growing concentration, considering both its structure modification and its internal 
energy variation (Alfinito et al., 2015).  In particular, we argue that the single aptamer 
electrical response, as well as  that of the single enzyme, are well reproduced by an impedance 
network analogue.  The differences between these two networks are in the static electrical 
properties which are specific for the chosen biomolecule.  Furthermore, the aptamer-enzyme 
complex is itself represented by an impedance network and the global electrical response is due 
to the cooperative action of the component networks. 
In our opinion the proposed approach is more interesting than previous ones (Hou et al.,  2006; 
Hou et al., 2007; Alfinito et al., 2013; Alfinito and Reggiani, 2014; Alfinito and Reggiani, 
2015). It aims to verify whether  a procedure born for proteins fits well also for different kinds 
of biomolecules, and  whether a single impedance network is a valid model of the expected 
global electrical response of a biological compound.  
This novel model takes advantage of recent data concerning some electrical properties of 
aptamers, i.e. polarizability  (Šponer, et al., 2002) and resistivity (Ohshiro et al., 2012). The 
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proposed electrical description gives a novel powerful tool for testing the aptamer-protein 
affinity.  The results  clearly  show that a resistance measurement is able to recognize whether 
the protein-aptamer complex has been performed in the presence of K+ or Na+ ions. Since the 
complex formed in the presence of K+ is more stable (Russo-Krauss et al., 2012), the resistance 
measurement  seems to be a novel tool for  resolving  different affinities.  
As far as we know, there is not another electrical microscopic modeling formulated for 
aptamers.  
 
 
2.Materials  
The thrombin binding DNA aptamer, 5’-GGT TGG TGT GGT TGG-3` is a SELEX product 
able to bind the blood coagulation enzyme thrombin. Its tertiary structure has been resolved 
with crystallographic (Schultze et al., 1994; Russo-Krauss et al., 2012) and  computational 
(Bini et al., 2011) techniques.  
In performing our investigations we considered:  
 a.  TBA in the native state (without the enzyme, in the wild configuration), hereafter called 
TBAnat;  
b.  TBA complexed (with the enzyme, in the binding configuration), hereafter called TBAcom; 
c. TBA in the active state (without the enzyme, in the binding configuration), hereafter called 
TBAact. 
The 3D structure we used for describing TBAnat  is the PDB entry 148D (Schultze  et al., 1994; 
Berman et al., 2000), which is an NMR product with 12 different outputs. For TBAcom we used 
the entries 4DII and 4DIH (Russo-Krauss et al., 2012; Berman et al., 2000), X-ray structures of 
the aptamer-protein complex resolved in the presence of potassium and sodium ions, 
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respectively.  Different effects exerted by Na+ and K+ on the inhibitory activity of TBA are also 
analyzed within our model. The TBAact structures were obtained by cutting off the protein from  
those of  TBAcom.  
The tertiary structures were used as the input of the model shown in Section 3.  
 
 
3. Experiment and Theory 
Experiment 
The experiments performed by Cai et al. (2006), used Au electrodes functionalized with the 
aptamer 5’-thiol-TTT TTT GGT TGG TGT GGT TGG-3` whose core is TBA, and incubated 
with different concentrations of thrombin. After incubation electrochemical measurements 
were performed and the impedance spectra recorded. The plane representation of this spectrum 
is known as Nyquist plot. The semicircle diameter of the plot gives the electron transfer 
resistance Rct. The formation of the TBA-thrombin complex monotonically enlarges the value 
of Rct.  
Our aim is to reproduce these data by using the model proposed in the following. 
Theory 
The electrical response is here described by using a model that conjugates  structure and 
function of the single biomolecule. This choice aims to mimic a fundamental paradigm in 
biology, i.e. tertiary structure induces function and vice versa. Accordingly, the model 
resolution is at the level of the single amino acid/nucleobase. Previous experience gained with 
sensing proteins (olfactory receptors, opsins, enzymes) has shown that this level of resolution 
is sufficient for  reproducing the electrical  properties measured in macroscopic devices 
(Alfinito et al., 2015).  
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Biomolecule structure is reproduced by using a graph. By taking the C1 and Cα carbon atoms as 
the centroids of each nucleobase/amino acid,  their position  is mapped into the position of a 
node of the graph. Then, two nodes are connected to form a link only if their distance is smaller 
than an assigned interaction radius, RC.  
Figure 1a represents the graph of the TBAnat  (PDB entry 148D_1, RC =10.1 Å). Figure 1b 
shows the graph of the TBAcom (PDB entry 4DII, RC =10.1 Å ). 
 
Figure 1a. Graph of the TBA  in the native state. The 
3D structure is taken by the PDB entry 148D_1, 
RC=10.1 Å  (Berman et al., 2000). 
Figure 1b. Graph of the TBA-thrombin complex. The 3D 
structure is taken by the PDB entry 4DII, RC=10.1 Å  
(Berman et al., 2000). 
 
 
Each link mimics a specific electrical interaction, as observed in experiments (Hou et al., 2007; 
Alfinito et al., 2015). Specifically, the impedance measurements performed by Cai et al. 
(2006), are interpreted in terms of a macroscopic Randles cell made of 4 passive elements, i.e., 
the electron-transfer resistance, Ret,  the solution resistance, the double-layer capacitance, Cdl, 
and the Warburg impedance, which is  the linear part of the lowest frequency range and 
represents the diffusion-limited electron-transfer process (Cai et al., 2006).  
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In the actual experimental design the Warburg impedance is not foreseen, thus  the thrombin 
injection changes the values of only two of these elements, say Ret and Cdl, connected in 
parallel.  Therefore, only Ret and Cdl were taken into account for modeling the electrical 
properties of the biomolecules. In other words, each link  is replaced by an elemental 
impedance, describing the charge transfer and/or the charge polarization  across the aptamer or 
the aptamer-protein complex. Since this is the relevant information for analyte detection, this is 
also the only electrical interaction we take into account. Therefore, each link  is replaced by an 
elemental impedance, describing the charge transfer and/or the charge polarization  across the 
aptamer or the aptamer-protein complex. 
The elemental impedance is that of an RC parallel circuit:  
a,b
a,b -1
a,b a,b a,b 0
l 1Z =
A ρ +iε ε ω
                                                         (1) 
where  Aa,b=π (RC2 – la,b2/4) is the cross-sectional area between spheres of radius RC centered on 
the a-th  and b-th node, respectively; la,b is the distance between these centers, i= -1  is the 
imaginary unit,  ε0 is the vacuum permittivity, ω is the circular frequency of the applied 
voltage. The relative dielectric constant of the couple of a-th and b-th amino-acids, εa,b, is 
expressed in terms of the intrinsic polarizability of each isolated amino acid/nucleobase, αelec.  
In particular, ( ) 2/
3
41 ,,, jelecielecjir α+απ+=ε .  
The resistivity of the l-th nucleobase is ll δρ=ρ , where  ρ  is the mean value calculated upon 
the AGCTU set  (Ohshiro et al., 2012). The resistivity of the link between the a-th  and the b-th 
nucleobase is defined as ( )
2
, baba
N δ+δρ=ρ  . Analogous data are not given for amino acids, 
therefore we assume that  their resistivities are  proportional to ρ ,   ργ=ρ A , with γ the same 
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for all the amino acids. The possible value of γ will be briefly discussed in the following. The 
link resistance of a couple of amino acids is, again, Aρ .  For both the relative dielectric 
constants and resistivities, we assume that previous formulas also hold in the aptamer-thrombin 
contact regions in which amino acids and nucleobases are connected between them. In 
particular, for the couple  of the a-th nucleobase and b-th amino acid, the link resistance is: 
( )
2
,
γ+δρ=ρ abaNA .  
In other terms, we assume the concept of a linear superposition of the effects, i.e., each couple 
of nodes has a specific value of polarizability and resistivity which depends only on the 
selected nodes. The presence of the other nodes in the network or the position of the couple in 
the network does not affect this result. This also means that, in this study,  the electric and 
dielectric effects of water and dissolved electrolytes are explicitly not considered. It is well 
known that this matter is quite hard to investigate also by using the effective methods of 
molecular dynamics calculations (Madan et al., 2016 ). In particular, the presence of solvent 
may play a role in  the dielectric properties of the biomolecules and has been described by 
using both  models which use distance-dependent dielectric constants and continuum 
electrostatic models (Gilson and Zhou, 2007) .The inclusion of solvent mainly affects the 
surface regions of the molecules and may be described like a non-uniform distribution of 
polarizabilities inside the biomolecule (Honig and Nicholis, 1995; Gilson  and Zhou, 2007; 
Špooner et al., 2002). In particular, these values are larger close the surfaces (due to the 
presence of water) and smaller inside the protein. Finally, concerning the binding, the solvent 
effect is described by an increasing of the solvation energy of conformations with larger 
surface areas, i.e. by favoring the conformations with smaller surface areas (Gilson  and Zhou, 
2007).  
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For a biomolecule small as the TBA, probably the concept of surface area is not well defined 
and the choice of using the isolated polarizabilities for the whole aptamers is not in contrast 
with the presence of the solvent. Therefore,  the same choice has been made for the protein and 
the aptamer-protein complex. On the other hand, the role of electrolytes in the formation of the 
aptamer- protein complex is here implicitly considered, by analyzing the electrical properties 
of complexes obtained in the presence of two different cations. Finally, as far as we know, an 
explicit role of solvent in the electrical transport properties is not verified. 
The network is connected to an external bias by means of ideal contacts  put on the first 
and last nucleobase and electrically solved by using standard techniques. In particular, by using 
the node Kirchhoff’s  law, the problem statement is expressed by  a set of linear equations that 
are numerically solved by a standard computational procedure (Alfinito et al., 2008, 2010, 
2011 ).  
Concerning the process of TBA-thrombin conjugation, it is here described by mimicking  
protein activation due to the specific ligand. The mechanism of protein activation is a long time 
debated problem (Onuchic et al., 1997; Miyashita et al., 2005; Kobilka and Deupi, 2007; Park 
et al., 2008 ). The most recent models  go beyond the lock-and-key scheme, by considering 
protein activation as the result of multiple pathways along and between energy funnels 
(Onuchic et al., 1997; Kobilka and Deupi, 2007; Alfinito and Reggiani, 2015). Each energy 
funnel is built up on a specific stable (ground) state, the native state (native funnel) or the 
binding state (binding funnel), for example. Analogously, we argue that when an aptamer folds 
from  the molten state to the native state, its free energy, so as its conformational entropy, 
becomes  smaller and smaller. This process is described by the aptamer sliding down an energy 
funnel (the native funnel), toward its minimum energy state (the native state).  The interaction 
with thrombin  may produce the binding or simply a variation of its free energy. In terms of the 
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energy funnel description, the aptamer changes its state from native to binding, moving from 
the native funnel toward  the binding funnel,  or it stays in the initial funnel, but  goes toward a 
higher energy state.  In the impedance network analogue, both these kinds of dynamics go with 
a change of RC.  This is also in analogy with protein dynamics, since in going up and down 
among the states, the protein changes the number of its internal bonds, retaining only those 
useful for stabilizing its final configuration (Kobilka and Deupi, 2007).  
Furthermore, when a sample receives its specific target, in general and if the target 
concentration is not huge, only a fraction of the aptamers  binds the target and this is at the 
origin of the dose-response mechanism.  
In particular, the dose-response given by experiments may be reproduced by using a Hill-like 
relation between  the fraction of aptamer-protein complex,  f,  and the value of RC (Alfinito and 
Reggiani, 2015): 
a
a
xb
xf +=                                                        (2) 
where 00 /)( RRRx C−= , R0 is the value of RC corresponding to f=0  i.e., a sample  consisting 
only of TBAs in their native state, and a and b are numerical fitting parameters. 
Finally, the sample resistance is given by:  
[ ]natcomsample r)f1(rfNr ×−+×=                                        (3) 
where N is the number of aptamers in the sample, rnat and rcomt are the single aptamer and the 
single aptamer-thrombin complex resistances, respectively. 
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4. Results 
a. General results: single biomolecule 
As a first step, we calculated the global resistances of  TBAnat and TBAact . Numerical results 
are reported in Figures 2a, 2b. 
We found that all the 12 native structures show a resistance smaller  than that of the active 
state, in particular for RC values close to 10 Å. Specifically, TBAact, in the presence of both Na+ 
and K+,  exhibits a relative resistance variation, rrv=ract/rnat -1 greater than 300%  when 
compared with the four native structures 148D_1, 148D_5, 148D_6, 148D_8. Such a greater 
resistance of TBAact with respect to TBAnat , indicates it has a more disconnected or dilated 
structure. Since we are interested in selecting one couple of structures with large resistance 
resolution, as shown by experiments, we focus on the first sequence of the native states, 
148D_1, whose rrv value is intermediate among that of the four aforementioned native 
structures.  We notice that the results are quite independent on the kind of ions used for 
resolving the TBAact structures.  
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Figure 2a. The relative resistances of the aptamer 
activated in the presence of potassium ions and in the 
native state. The active state is taken by the PDB entry 4DII 
(Russo-Krauss et al., 2012), while the native states come from 
the PDB entry 148D (Berman et al., 2000). Calculations are 
performed at growing values of RC. The structures of the 
native states which produce the largest differences with 
respect the activated state (1,5,6,8) are in black. 
Figure 2b. The relative resistances of the aptamer 
activated in the presence of sodium ions and in the native 
state. The active state is taken by the PDB entry 4DIH 
(Russo-Krauss et al., 2012), while the native states come from 
the PDB entry 148D (Berman et al., 2000).  Calculations are 
performed at growing values of RC. The structures of the 
native states which produce the largest differences with 
respect the activated state (1,5,6,8) are in black. 
Thrombin significantly changes these outcomes.  To this purpose, Figures 3a and 3b report  
rrv=rcom/rnat -1  of the structures TBAcom and 148D_1. The presence of the thrombin strongly 
reduces the differences observed in previous  simulations, i.e., by using TBAact instead of  
Figure 3a. The relative resistances of the aptamer-
thrombin complex in the presence of potassium ions and 
the native state. The complex structure is taken by the PDB 
entry 4DII (Russo-Krauss et al., 2012), while the native 
structure comes from the PDB entry 148D_1 (Berman et al., 
2000).  Calculations were performed at growing values of 
RC  and of  γ,  the proportionality factor of the amino acid 
resistivities (see text). 
Figure 3b. The relative resistances of the aptamer-
thrombin complex in the presence of sodium ions and 
the native state. The complex state is taken by the PDB 
entry 4DIH  (Russo-Krauss et al., 2012), while the native 
state comes from the PDB entry 148D_1 (Berman et al., 
2000).  Calculations were performed at growing values of 
RC and of γ,  the proportionality factor of the amino acid 
resistivities (see text). 
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TBAcom , rrv falls from  about 300% to 50%  for the complex obtained in the presence of K+ 
and to 25% for the complex obtained in the presence of Na+. 
As a matter of fact, thrombin completes the aptamer network, thus enhancing the number of 
connections and reducing the value of global resistance. This happens in different ways for the 
two structures, thus revealing that the binding is different. In particular, the formation of the 
aptamer-thrombin complex is promoted by the presence of K+ (Russo-Krauss et al., 2012). 
Therefore, this result suggests resistance measurements as a complementary  test of the 
aptamer-thrombin affinity. 
We have also tested the role of the resistivity proportionality factor γ , introduced in Section 3 
(see Figures 3a and 3b). By increasing this value, the resistance of the aptamer-enzyme 
complex grows, as expected. On the other hand, this variation is not so massive to definitely 
suggest a value of γ larger than 1.  
 
b.  Comparison with experimental dose response 
To compare theory and experiment, it is necessary to rescale the results obtained for the single 
biomolecule to the sample size. In particular, as described in the Theory subsection, we conjecture 
that, by increasing the thrombin concentration, the number of aptamers in the complex state becomes 
larger and that also the free energy of each aptamer becomes higher.  
Accordingly, we select R0=13.3 Å as the interaction radius useful to calculate the resistance of the 
single TBA in the native state. This value is the largest corresponding to the region in which, in 
agreement with experiments, the resistance of TBAcom is larger than that of TBAnat (see Figures 3).  
The sample resistance is given by eq.(3) with f=0, up to N .  When the free energy of each aptamer 
changes,  the RC value decreases (Alfinito et al., 2011)  and its value is related to the value of f  by 
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eq.(3). Finally, eq.(3) allows us to reproduce the resistance variation of the sample as given by 
experiments (dose-response). The rate r/r0 of the sample Rct  measured for different thrombin 
concentrations with respect the sample Rct  without thrombin, the corresponding values of RC and the 
fraction , f, of aptamer-thrombin complexes are summarized in Table 1. 
Concentration (M)               r/r0 RC (Å) f 
         1.0 10-6 3.2 11.3 0.93 
         1.0 10-8 2.1 11.5 0.90 
1.0 10-10 1.8 11.7 0.87 
1.0 10-12 1.2 12.7 0.26 
 
 
Table I. Summary of the experimental dose response results and theoretical data used to reproduce them.  
First column indicates the thrombin concentration in molar, by  Cai et al. (2006) -experiment-;  column 2  is the ratio 
between the resistance (r0) of a sample not exposed to the thrombin, and the resistance (r) of a  sample at  the thrombin 
concentrations indicated in column 1 –experiment-. Column 3 gives the values of the interaction radius (RC) used for 
calculating the fraction (f) of aptamer-protein complexes –theory-, column 4 gives the f values (see eq.2) –theory-. 
 
The corresponding Nyquist plots,  as calculated within this model, are reported in  Figure 4.   
 
 
Figure 4. The Nyquist plots of the aptamer-thrombin complex in the presence of potassium ions and the native state. 
Dashed line represent the sample response given by  93% of TBA-thrombin complex (PDB entry 4DII), and 7% of TBA in 
the native (PDB entry 148D_1), the value of RC is 11.3 Å.  Continuous line represents the response of a sample made of 
100% of aptamers in the  native state (PDB entry 148D_1), RC , is 13.3 Å.   
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In particular, we report the Nyquist plot corresponding to a sample in which all the aptamers are in the 
native state, RC=R0=13.3 Å,  and the Nyquist plot of a sample with the 93% of aptamers binding  
thrombin and RC=11.3 Å, as given by eq.(2).  
 Finally,  the plot of the Hill-like equation (2),  is drawn in Figure 5. The fitting parameters are a=2.99 
and b=2.7 10-4.     
In the inset of this figure we report  the relative difference rT/rR -1 of the sample resistance measured at 
different concentrations of thrombin, rT, and the  resistance of the reference sample (without 
thrombin), rR, as function  of  the RC values we used for  fitting the percentage of aptamer-thrombin 
complex. 
 
 
 
Figure 5. The fraction of TBA-thrombin biomolecules used to fit the experiments (Cai et al., 2006). Dots refer to the thrombin 
concentrations given in the experiments.  Continuous line is the fit performed by using the Hill-like function described in the text. In the 
inset the relative resistance of the sample measured at different concentrations of thrombin, rT, and that of the reference sample (without 
thrombin), rR as given by experiments, are reported in correspondence of the RC values we for the Hill fitting, as in the main figure. 
 
 
 
4.Discussion and Conclusions 
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Aptamers are a new promising group of  bioreceptors, because of their outstanding selectivity, 
sensitivity and stability (Strehlitz et al., 2008). Especially aptamer-based clinical label-free 
devices are widely recognized as the new frontier in diagnosis as well as in therapy. 
Unfortunately,  poor information is at present available concerning the mechanisms of 
aptamer activation, so going deeper in this field is extremely challenging.  
In this paper we detailed and tested a microscopic model useful for the description of the 
electrical properties of aptamers and aptamer-protein complexes, by using  analogue 
impedance networks. The plug-in of aptamer and protein activates an electrical 
communication between them which results in the modification of the electrical response of 
the aptamer alone.  
In particular, we analyzed the electrical response of three different structures, the aptamer in 
the native state, TBAnat , and the aptamer in the binding state, without the thrombin, TBAact , 
and with the thrombin, TBAcom. The relative resistance variation, rrv=ract/rnat -1  calculated 
for TBAnat and TBAact is large, when compared with experiments but when the protein is 
added (TBAact is substituted by TBAcom) it becomes comparable with experiments. This result 
suggests that the resistance growth is not only a passivation effect due to the addition of a 
hydrophobic layer of proteins (Cai et al., 2006), but that the role of the specific structural 
docking is relevant, since the protein completes the impedance network and reduces the 
resistance which would have been measured in a sample with the aptamers activated but not 
bound to the protein.  
Furthermore, the model predicts that a  resistance measurement is a good test of the protein-
aptamer affinity. The model is validated on EIS measurements performed by Cai et al. (2006) 
on TBA samples exposed to growing concentration of thrombin. 
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Finally, monitoring the change of Ret obtained from EIS promises a sensitive and reliable 
protein label-free biosensor. The interpretation of these data by using a simple network 
impedance is a new success of proteotronics methods. All these findings could accelerate the 
development of label-free biosensors of practical relevance.  
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